Skip to main content

Table 2 Prevalence of malaria in pregnant women in antenatal care (N = 2 044)

From: Coverage of intermittent prevention treatment with sulphadoxine-pyrimethamine among pregnant women and congenital malaria in Côte d'Ivoire

  

IPT-SP dose

 

Total

(N = 2 044)

0

(n = 333)

1

(n = 694)

2

(n = 821)

≥3

(n = 196)

P value

Mothers

      

Peripheral cord blood positive

      

   Rapid Malaria test (ACON®)

21 (1.0)

6 (1.8)

8 (1.2)

6 (0.7)

1 (0.5)

0.358

   95% Confidence interval

[0.64-1.57]

[0.66 - 3.88]

[0.50-2.26]

[0.27-1.58]

[0.00-2.81]

 

   Blood smears

19 (0.9)

6 (1.8)

7 (1.0)

6 (0.7)

0 (0.0)

0.564

   95% Confidence interval

[0.56-1.44]

[0.66 - 3.88]

[0.41-2.07]

[0.27-1.58]

[0.00-1.86]

 

Placental blood positives

      

   Rapid Malaria test (ACON®)

109 (5.3)

39 (11.7)

34 (4.9)

27 (3.3)

9 (4.6)

< 0.001

   95% Confidence interval

[4.40-6.40]

[8.46-15.66]

[3.42-6.78]

[2.18-4.75]

[2.12-8.54]

 

   Blood smears

99 (4.8)

39 (11.7)

31 (4.5)

23 (2.8)

6 (3.1)

0.026

   95% Confidence interval

[3.95 - 5.86]

[8.46-15.66]

[3.05-6.28]

[1.78 - 4.17]

[1.13-6.54]

 

Neonates

      

   Number of available specimens*

85

35

26

19

5

 

   Peripheral blood positives

4 (4.7)

2 (5.7)

1 (3.8)

1 (5.3)

0 (0.0)

1.00

   95 % Confidence interval

[1.30-11.61]

[0.70-19.16]

[0.10-19.64]

[0.13-26.03]

[0.00-52.18]

 
  1. * From mothers with placenta blood positive
  2. ε One missing observation
  3. IQR: Interquartile range
  4. IPT-SP: Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine
  5. ITNs: insecticide-treated mosquito nets